Search

everythinglearnresearchcommunity

for

Search:↓

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

A new compound shows promise as a topical treatment for hair loss.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Upadacitinib may effectively treat resistant lichen planopilaris.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

INT effectively shows enzyme activity and protein groups in wool and hair follicles.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Docetaxel is effective against various cancers but mainly causes neutropenia.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

The document's conclusion cannot be provided because the text is not in a processable format.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Triamcinolone acetonide injections effectively treat skin disorders like eczema and psoriasis.

Baricitinib helps regrow hair in teens with severe alopecia areata.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Ectoin helps prevent cortisone-induced skin problems and supports skin health.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.